Ligand · 4MG
4MG · 1-[(3-methyl-1-{2-[(1,2,3-trimethyl-1H-indol-5-yl)amino]pyrimidin-4-yl}-1H-pyrazol-4-yl)methyl]azetidin-3-ol
4MG, 1-[(3-methyl-1-{2-[(1,2,3-trimethyl-1H-indol-5-yl)amino]pyrimidin-4-yl}-1H-pyrazol-4-yl)methyl]azetidin-3-ol (C23 H27 N7 O, 417.5 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with…
- Component
- 4MG
- Formula
- C23 H27 N7 O
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
4MG in 2 structures; the first of them:
- 4RSS · Crystal structure of tyrosine-protein kinase SYK with an inhibitor · 4MG A701 · binds LEU377, GLY378, VAL385, ALA400, LYS402, GLU420, VAL433, MET448 and 12 more
- 4RSS · Crystal structure of tyrosine-protein kinase syk with an inhibitor · 4MG A701 · binds LEU377, GLY378, VAL385, ALA400, LYS402, GLU420, VAL433, MET448 and 12 more
Residues it binds most
GLU 2, LEU 2, ALA 2, GLY 2, MET 2, VAL 2, ARG 2, ASN 2, ASP 2, LYS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.